Mar 11, 2010
Genmab to attend Kempen & Co Life Sciences

Mar 8, 2010
Genmab Announces Results from Zalutumumab Phase III Study of Refractory Head and Neck Cancer Patients

Mar 2, 2010
Genmab Announces Year End 2009 Financial Results

Feb 4, 2010
Genmab Outlicenses Zanolimumab to TenX Biopharma

Feb 4, 2010
Arzerra 2009 Net Sales Figures

Feb 3, 2010
Major Shareholder Announcement

Jan 22, 2010
Arzerra (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lymphocytic Leukaemia

Jan 18, 2010
Major Shareholder Announcement for Genmab A/S